Nu Skin Enterprises, Inc. (NYSE: NUS) Stock Competitors & Peer Comparison
See NUS's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NUS and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NUS | $4.80 | -1.03% | 233.3M | 4.00 | $1.20 | +4.98% |
| PG | $144.55 | +0.20% | 343.6B | 20.83 | $6.94 | +2.97% |
| UL | $62.09 | -0.94% | 133.8B | 20.42 | $3.04 | +3.57% |
| CL | $91.95 | -1.05% | 73.6B | 24.52 | $3.75 | +2.29% |
| KVUE | $19.20 | +0.00% | 36.8B | 16.26 | $1.18 | +4.33% |
| KMB | $110.39 | -0.28% | 36.6B | 14.82 | $7.45 | +4.60% |
| EL | $86.10 | -1.40% | 31.1B | 38.95 | $2.21 | +1.62% |
| CHD | $101.30 | -0.02% | 24B | 28.46 | $3.56 | +1.21% |
| CLX | $105.70 | -0.79% | 12.8B | 19.08 | $5.54 | +4.72% |
| REYN | $26.25 | -0.23% | 5.5B | 15.35 | $1.71 | +3.51% |
Stock Comparison
The Procter & Gamble Company (NYSE: PG)
NUS vs PG Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, PG has a market cap of 343.6B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while PG trades at $144.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas PG's P/E ratio is 20.83. In terms of profitability, NUS's ROE is -0.29%, compared to PG's ROE of +0.30%. Regarding short-term risk, NUS is more volatile compared to PG. This indicates higher risk in terms of short-term price fluctuations for NUS.Check PG's competition here
Unilever PLC (NYSE: UL)
NUS vs UL Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, UL has a market cap of 133.8B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while UL trades at $62.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas UL's P/E ratio is 20.42. In terms of profitability, NUS's ROE is -0.29%, compared to UL's ROE of +0.36%. Regarding short-term risk, NUS is more volatile compared to UL. This indicates higher risk in terms of short-term price fluctuations for NUS.Check UL's competition here
Colgate-Palmolive Company (NYSE: CL)
NUS vs CL Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, CL has a market cap of 73.6B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while CL trades at $91.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas CL's P/E ratio is 24.52. In terms of profitability, NUS's ROE is -0.29%, compared to CL's ROE of +6.31%. Regarding short-term risk, NUS is more volatile compared to CL. This indicates higher risk in terms of short-term price fluctuations for NUS.Check CL's competition here
Kenvue Inc. (NYSE: KVUE)
NUS vs KVUE Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, KVUE has a market cap of 36.8B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while KVUE trades at $19.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas KVUE's P/E ratio is 16.26. In terms of profitability, NUS's ROE is -0.29%, compared to KVUE's ROE of +0.16%. Regarding short-term risk, NUS is more volatile compared to KVUE. This indicates higher risk in terms of short-term price fluctuations for NUS.Check KVUE's competition here
Kimberly-Clark Corporation (NASDAQ: KMB)
NUS vs KMB Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, KMB has a market cap of 36.6B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while KMB trades at $110.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas KMB's P/E ratio is 14.82. In terms of profitability, NUS's ROE is -0.29%, compared to KMB's ROE of +1.23%. Regarding short-term risk, NUS is more volatile compared to KMB. This indicates higher risk in terms of short-term price fluctuations for NUS.Check KMB's competition here
The Estée Lauder Companies Inc. (NYSE: EL)
NUS vs EL Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, EL has a market cap of 31.1B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while EL trades at $86.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas EL's P/E ratio is 38.95. In terms of profitability, NUS's ROE is -0.29%, compared to EL's ROE of -0.06%. Regarding short-term risk, NUS is more volatile compared to EL. This indicates higher risk in terms of short-term price fluctuations for NUS.Check EL's competition here
Church & Dwight Co., Inc. (NYSE: CHD)
NUS vs CHD Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, CHD has a market cap of 24B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while CHD trades at $101.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas CHD's P/E ratio is 28.46. In terms of profitability, NUS's ROE is -0.29%, compared to CHD's ROE of +0.18%. Regarding short-term risk, NUS is more volatile compared to CHD. This indicates higher risk in terms of short-term price fluctuations for NUS.Check CHD's competition here
The Clorox Company (NYSE: CLX)
NUS vs CLX Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, CLX has a market cap of 12.8B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while CLX trades at $105.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas CLX's P/E ratio is 19.08. In terms of profitability, NUS's ROE is -0.29%, compared to CLX's ROE of -18.94%. Regarding short-term risk, NUS is more volatile compared to CLX. This indicates higher risk in terms of short-term price fluctuations for NUS.Check CLX's competition here
Reynolds Consumer Products Inc. (NASDAQ: REYN)
NUS vs REYN Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, REYN has a market cap of 5.5B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while REYN trades at $26.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas REYN's P/E ratio is 15.35. In terms of profitability, NUS's ROE is -0.29%, compared to REYN's ROE of +0.15%. Regarding short-term risk, NUS is more volatile compared to REYN. This indicates higher risk in terms of short-term price fluctuations for NUS.Check REYN's competition here
e.l.f. Beauty, Inc. (NYSE: ELF)
NUS vs ELF Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, ELF has a market cap of 5.4B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while ELF trades at $91.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas ELF's P/E ratio is 22.93. In terms of profitability, NUS's ROE is -0.29%, compared to ELF's ROE of +0.05%. Regarding short-term risk, NUS is less volatile compared to ELF. This indicates lower risk in terms of short-term price fluctuations for NUS.Check ELF's competition here
Natura &Co Holding S.A. (NYSE: NTCO)
NUS vs NTCO Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas NTCO's P/E ratio is -11.37. In terms of profitability, NUS's ROE is -0.29%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, NUS is more volatile compared to NTCO. This indicates higher risk in terms of short-term price fluctuations for NUS.Check NTCO's competition here
Inter Parfums, Inc. (NASDAQ: IPAR)
NUS vs IPAR Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, IPAR has a market cap of 3.7B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while IPAR trades at $114.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas IPAR's P/E ratio is 21.92. In terms of profitability, NUS's ROE is -0.29%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, NUS is less volatile compared to IPAR. This indicates lower risk in terms of short-term price fluctuations for NUS.Check IPAR's competition here
Central Garden & Pet Company (NASDAQ: CENT)
NUS vs CENT Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, CENT has a market cap of 2.7B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while CENT trades at $43.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas CENT's P/E ratio is 14.82. In terms of profitability, NUS's ROE is -0.29%, compared to CENT's ROE of +0.10%. Regarding short-term risk, NUS is less volatile compared to CENT. This indicates lower risk in terms of short-term price fluctuations for NUS.Check CENT's competition here
Newell Brands Inc. (NASDAQ: NWL)
NUS vs NWL Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, NWL has a market cap of 2.7B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while NWL trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas NWL's P/E ratio is 11.56. In terms of profitability, NUS's ROE is -0.29%, compared to NWL's ROE of -0.09%. Regarding short-term risk, NUS is less volatile compared to NWL. This indicates lower risk in terms of short-term price fluctuations for NUS.Check NWL's competition here
Coty Inc. (NYSE: COTY)
NUS vs COTY Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, COTY has a market cap of 2.5B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while COTY trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas COTY's P/E ratio is 15.81. In terms of profitability, NUS's ROE is -0.29%, compared to COTY's ROE of -0.15%. Regarding short-term risk, NUS is less volatile compared to COTY. This indicates lower risk in terms of short-term price fluctuations for NUS.Check COTY's competition here
Spectrum Brands Holdings, Inc. (NYSE: SPB)
NUS vs SPB Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, SPB has a market cap of 2.1B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while SPB trades at $89.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas SPB's P/E ratio is 13.83. In terms of profitability, NUS's ROE is -0.29%, compared to SPB's ROE of +0.04%. Regarding short-term risk, NUS is more volatile compared to SPB. This indicates higher risk in terms of short-term price fluctuations for NUS.Check SPB's competition here
Edgewell Personal Care Company (NYSE: EPC)
NUS vs EPC Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, EPC has a market cap of 1.3B. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while EPC trades at $28.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas EPC's P/E ratio is 15.45. In terms of profitability, NUS's ROE is -0.29%, compared to EPC's ROE of -0.06%. Regarding short-term risk, NUS is more volatile compared to EPC. This indicates higher risk in terms of short-term price fluctuations for NUS.Check EPC's competition here
Oddity Tech Ltd. (NASDAQ: ODD)
NUS vs ODD Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, ODD has a market cap of 747.2M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while ODD trades at $13.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas ODD's P/E ratio is 10.08. In terms of profitability, NUS's ROE is -0.29%, compared to ODD's ROE of +0.14%. Regarding short-term risk, NUS is less volatile compared to ODD. This indicates lower risk in terms of short-term price fluctuations for NUS.Check ODD's competition here
Helen of Troy Limited (NASDAQ: HELE)
NUS vs HELE Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, HELE has a market cap of 703.9M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while HELE trades at $30.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas HELE's P/E ratio is 9.16. In terms of profitability, NUS's ROE is -0.29%, compared to HELE's ROE of -0.48%. Regarding short-term risk, NUS is more volatile compared to HELE. This indicates higher risk in terms of short-term price fluctuations for NUS.Check HELE's competition here
The Honest Company, Inc. (NASDAQ: HNST)
NUS vs HNST Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, HNST has a market cap of 532.8M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while HNST trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas HNST's P/E ratio is 75.87. In terms of profitability, NUS's ROE is -0.29%, compared to HNST's ROE of -0.07%. Regarding short-term risk, NUS is less volatile compared to HNST. This indicates lower risk in terms of short-term price fluctuations for NUS.Check HNST's competition here
Magnera Corp (NYSE: MAGN)
NUS vs MAGN Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, MAGN has a market cap of 444.3M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while MAGN trades at $12.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas MAGN's P/E ratio is -6.04. In terms of profitability, NUS's ROE is -0.29%, compared to MAGN's ROE of -0.11%. Regarding short-term risk, NUS is less volatile compared to MAGN. This indicates lower risk in terms of short-term price fluctuations for NUS.Check MAGN's competition here
European Wax Center, Inc. (NASDAQ: EWCZ)
NUS vs EWCZ Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, NUS's ROE is -0.29%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, NUS is more volatile compared to EWCZ. This indicates higher risk in terms of short-term price fluctuations for NUS.Check EWCZ's competition here
Yatsen Holding Limited (NYSE: YSG)
NUS vs YSG Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, YSG has a market cap of 316.9M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while YSG trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas YSG's P/E ratio is -26.45. In terms of profitability, NUS's ROE is -0.29%, compared to YSG's ROE of -0.05%. Regarding short-term risk, NUS is less volatile compared to YSG. This indicates lower risk in terms of short-term price fluctuations for NUS.Check YSG's competition here
USANA Health Sciences, Inc. (NYSE: USNA)
NUS vs USNA Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, USNA has a market cap of 246.5M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while USNA trades at $13.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas USNA's P/E ratio is 13.48. In terms of profitability, NUS's ROE is -0.29%, compared to USNA's ROE of -0.04%. Regarding short-term risk, NUS is less volatile compared to USNA. This indicates lower risk in terms of short-term price fluctuations for NUS.Check USNA's competition here
Acme United Corporation (AMEX: ACU)
NUS vs ACU Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, ACU has a market cap of 231.8M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while ACU trades at $60.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas ACU's P/E ratio is 26.22. In terms of profitability, NUS's ROE is -0.29%, compared to ACU's ROE of +0.08%. Regarding short-term risk, NUS is less volatile compared to ACU. This indicates lower risk in terms of short-term price fluctuations for NUS.Check ACU's competition here
Pitanium Limited (NASDAQ: PTNM)
NUS vs PTNM Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas PTNM's P/E ratio is 346.33. In terms of profitability, NUS's ROE is -0.29%, compared to PTNM's ROE of -0.99%. Regarding short-term risk, NUS is more volatile compared to PTNM. This indicates higher risk in terms of short-term price fluctuations for NUS.Check PTNM's competition here
Waldencast plc (NASDAQ: WALD)
NUS vs WALD Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, WALD has a market cap of 159.6M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while WALD trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas WALD's P/E ratio is -2.25. In terms of profitability, NUS's ROE is -0.29%, compared to WALD's ROE of -0.48%. Regarding short-term risk, NUS is less volatile compared to WALD. This indicates lower risk in terms of short-term price fluctuations for NUS.Check WALD's competition here
Waldencast plc (NASDAQ: WALDW)
NUS vs WALDW Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, WALDW has a market cap of 149.1M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while WALDW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas WALDW's P/E ratio is -0.05. In terms of profitability, NUS's ROE is -0.29%, compared to WALDW's ROE of -0.48%. Regarding short-term risk, NUS is less volatile compared to WALDW. This indicates lower risk in terms of short-term price fluctuations for NUS.Check WALDW's competition here
Solesence, Inc. Common Stock (NASDAQ: SLSN)
NUS vs SLSN Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, SLSN has a market cap of 73.5M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while SLSN trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas SLSN's P/E ratio is 84.55. In terms of profitability, NUS's ROE is -0.29%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, NUS is less volatile compared to SLSN. This indicates lower risk in terms of short-term price fluctuations for NUS.Check SLSN's competition here
Upexi, Inc. (NASDAQ: UPXI)
NUS vs UPXI Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, UPXI has a market cap of 54.9M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while UPXI trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas UPXI's P/E ratio is -0.17. In terms of profitability, NUS's ROE is -0.29%, compared to UPXI's ROE of -3.07%. Regarding short-term risk, NUS is less volatile compared to UPXI. This indicates lower risk in terms of short-term price fluctuations for NUS.Check UPXI's competition here
Grove Collaborative Holdings, Inc. (NYSE: GROV)
NUS vs GROV Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, GROV has a market cap of 43.7M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while GROV trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas GROV's P/E ratio is -4.00. In terms of profitability, NUS's ROE is -0.29%, compared to GROV's ROE of -0.83%. Regarding short-term risk, NUS is less volatile compared to GROV. This indicates lower risk in terms of short-term price fluctuations for NUS.Check GROV's competition here
Axil Brands, Inc. (AMEX: AXIL)
NUS vs AXIL Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, AXIL has a market cap of 41.5M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while AXIL trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas AXIL's P/E ratio is 50.71. In terms of profitability, NUS's ROE is -0.29%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, NUS is less volatile compared to AXIL. This indicates lower risk in terms of short-term price fluctuations for NUS.Check AXIL's competition here
United-Guardian, Inc. (NASDAQ: UG)
NUS vs UG Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, UG has a market cap of 32.8M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while UG trades at $7.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas UG's P/E ratio is 13.71. In terms of profitability, NUS's ROE is -0.29%, compared to UG's ROE of +0.22%. Regarding short-term risk, NUS is more volatile compared to UG. This indicates higher risk in terms of short-term price fluctuations for NUS.Check UG's competition here
Big Tree Cloud Holdings Limited (NASDAQ: DSY)
NUS vs DSY Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, DSY has a market cap of 20.2M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while DSY trades at $4.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas DSY's P/E ratio is -0.47. In terms of profitability, NUS's ROE is -0.29%, compared to DSY's ROE of +14.77%. Regarding short-term risk, NUS is less volatile compared to DSY. This indicates lower risk in terms of short-term price fluctuations for NUS.Check DSY's competition here
Mannatech, Incorporated (NASDAQ: MTEX)
NUS vs MTEX Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, MTEX has a market cap of 12M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while MTEX trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas MTEX's P/E ratio is -0.93. In terms of profitability, NUS's ROE is -0.29%, compared to MTEX's ROE of +3.37%. Regarding short-term risk, NUS is less volatile compared to MTEX. This indicates lower risk in terms of short-term price fluctuations for NUS.Check MTEX's competition here
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH)
NUS vs PHH Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas PHH's P/E ratio is -0.53. In terms of profitability, NUS's ROE is -0.29%, compared to PHH's ROE of +0.38%. Regarding short-term risk, NUS is less volatile compared to PHH. This indicates lower risk in terms of short-term price fluctuations for NUS.Check PHH's competition here
Bruush Oral Care Inc. (NASDAQ: BRSH)
NUS vs BRSH Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas BRSH's P/E ratio is -0.01. In terms of profitability, NUS's ROE is -0.29%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSH. This indicates lower risk in terms of short-term price fluctuations for NUS.Check BRSH's competition here
Tantech Holdings Ltd (NASDAQ: TANH)
NUS vs TANH Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, TANH has a market cap of 5.7M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while TANH trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas TANH's P/E ratio is 0.04. In terms of profitability, NUS's ROE is -0.29%, compared to TANH's ROE of -0.25%. Regarding short-term risk, NUS is less volatile compared to TANH. This indicates lower risk in terms of short-term price fluctuations for NUS.Check TANH's competition here
Park Ha Biological Technology Co., Ltd. Ordinary Shares (NASDAQ: BYAH)
NUS vs BYAH Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, BYAH has a market cap of 2.5M. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while BYAH trades at $3.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas BYAH's P/E ratio is N/A. In terms of profitability, NUS's ROE is -0.29%, compared to BYAH's ROE of -1.74%. Regarding short-term risk, NUS is less volatile compared to BYAH. This indicates lower risk in terms of short-term price fluctuations for NUS.Check BYAH's competition here
Bruush Oral Care Inc. (NASDAQ: BRSHW)
NUS vs BRSHW Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas BRSHW's P/E ratio is N/A. In terms of profitability, NUS's ROE is -0.29%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSHW. This indicates lower risk in terms of short-term price fluctuations for NUS.Check BRSHW's competition here
Elizabeth Arden, Inc. (NASDAQ: RDEN)
NUS vs RDEN Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas RDEN's P/E ratio is -5.68. In terms of profitability, NUS's ROE is -0.29%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, NUS is more volatile compared to RDEN. This indicates higher risk in terms of short-term price fluctuations for NUS.Check RDEN's competition here
Revlon, Inc. (NYSE: REV)
NUS vs REV Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, REV has a market cap of 0. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas REV's P/E ratio is -1.19. In terms of profitability, NUS's ROE is -0.29%, compared to REV's ROE of +0.89%. Regarding short-term risk, NUS is less volatile compared to REV. This indicates lower risk in terms of short-term price fluctuations for NUS.Check REV's competition here
Grove Collaborative Holdings, Inc. (NYSE: GROV-WT)
NUS vs GROV-WT Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, NUS's ROE is -0.29%, compared to GROV-WT's ROE of -0.83%. Regarding short-term risk, NUS is more volatile compared to GROV-WT. This indicates higher risk in terms of short-term price fluctuations for NUS.Check GROV-WT's competition here
Summer Infant, Inc. (NASDAQ: SUMR)
NUS vs SUMR Comparison August 2026
Nu Skin Enterprises, Inc. (NYSE: NUS) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 233.3M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, NUS is priced at $4.80 on the NYSE, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.00, whereas SUMR's P/E ratio is -3.66. In terms of profitability, NUS's ROE is -0.29%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, NUS is more volatile compared to SUMR. This indicates higher risk in terms of short-term price fluctuations for NUS.Check SUMR's competition here